Pdt Partners, LLC Opti Nose, Inc. Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.16 $32,430 - $43,608	-13,800 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.91 - $3.83 $176,346 - $232,098	-60,600 Reduced 81.45%	13,800 $43,000
Q1 2021 May 17, 2021	SELL	$3.47 - $4.75 $44,662 - $61,137	-12,871 Reduced 14.75%	74,400 $275,000
Q4 2020 Feb 16, 2021	SELL	$3.2 - $4.98 $14,080 - $21,912	-4,400 Reduced 4.8%	87,271 $361,000
Q3 2020 Nov 16, 2020	BUY	$3.69 - $7.09 $190,935 - $366,864	51,744 Added 129.6%	91,671 $358,000
Q2 2020 Aug 14, 2020	BUY	$3.58 - $7.44 $142,938 - $297,056	39,927 New	39,927 $297,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $40M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.